NCT05432895 Dynamic Versus Static Night Splinting of Plantar Fasciitis
| NCT ID | NCT05432895 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Plantar Fascitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-10-31 |
| Primary Completion | 2026-06-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-10-31 with a primary completion date of 2026-06-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.
Eligibility Criteria
Inclusion Criteria: * Demographic - Over 18 years of age and ambulatory without a gait aid with no history of narcotic use * Diagnosis - Unilateral or bilateral acute (\< 6 months of pain) plantar fasciitis (i.e., Heel pain that increases with weightbearing, "First step pain": heel pain that occurs after a period of non-weightbearing, such as in the morning when arising from bed or when arising after prolonged sitting; the pain is improved after a few minutes walking but will worsen again with prolonged weightbearing, tenderness over the medial calcaneal tuberosity at the insertion of the plantar fasciitis) * Permitted - Icing, NSAIDS( ibuprofen), Custom Shoe Inserts, Diagnostic Ultrasound Exclusion Criteria: * Demographic - Under 18 year of age, requires a gait aid for ambulation; if not covered by insurance, * Diagnosis of - Arthritis of the Ankle, Midfoot, or Forefoot; Inflammatory Arthritis; Gout; Turf Toe; Hallux Rigidus; Hallux Limitus; Sesamoiditis; Tendonitis or Tendinopathy; Prior tear or Rupture of the Plantar Fascia; Fibromyalgia, Neuralgia, or Neuropathy; Peripheral Vascular Disease; Prior Trauma to the Heel, Fracture of the Calcaneus; Infection; Corn; Callus; Ingrown Nail. * Patient with history of Symptoms for over 6 months * Refractory to prior splint-based treatments * Prior injection of the plantar fascia * Prior surgery on the plantar fascia * Narcotic use
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05432895 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Plantar Fascitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05432895 currently recruiting?
Yes, NCT05432895 is actively recruiting participants. Contact the research team at arprerna@stanford.edu for enrollment information.
Where is the NCT05432895 trial being conducted?
This trial is being conducted at Palo Alto, United States, Redwood City, United States.
Who is sponsoring the NCT05432895 clinical trial?
NCT05432895 is sponsored by Stanford University. The trial plans to enroll 200 participants.